NCT03171636View on ClinicalTrials.gov

Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

January 31, 2019

Conditions
Lung NeoplasmsKRAS Gene MutationEGFR Gene Mutation
Trial Locations (1)

81520-060

Hospital Erasto Gaertner, Curitiba

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Hospital Erasto Gaertner

OTHER